MTOR and acute lymphoblastic leukemia: Many other classes of medications are currently undergoing testing in r/r ALL, including monoclonal antibodies, demethylating agents, cell cycle inhibitors, BCL2 family inhibitors, and mechanistic targets of rapamycin (mTOR) inhibitors.8, 9, 10, 11